Search Results - "Renouf, B."

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program by Bello Roufai, D., Gonçalves, A., De La Motte Rouge, T., Akla, S., Blonz, C., Grenier, J., Gligorov, J., Saghatchian, M., Bailleux, C., Simon, H., Desmoulins, I., Tharin, Z., Renaud, E., Bertho, M., Benderra, M-A, Delaloge, S., Robert, L., Cottu, P., Pierga, J. Y., Loirat, D., Bertucci, A., Renouf, B., Bidard, F. C., Lerebours, F.

Get full text

Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program by Bello Roufai, D., Gonçalves, A., De La Motte Rouge, T., Akla, S., Blonz, C., Grenier, J., Gligorov, J., Saghatchian, M., Bailleux, C., Simon, H., Desmoulins, I., Tharin, Z., Renaud, E., Bertho, M., Benderra, M-A, Delaloge, S., Robert, L., Cottu, P., Pierga, J. Y., Loirat, D., Bertucci, A., Renouf, B., Bidard, F. C., Lerebours, F.

“…SOLAR-1 and BYLieve trials documented the efficacy of the PI3K-inhibitor alpelisib in pre-treated PIK3CA -mutant, hormone receptor-positive, HER2-negative…”
Get full text

Results of an international phosphorus digestibility ring test with broiler chickens by Rodehutscord, M, Adeola, O, Angel, R, Bikker, P, Delezie, E, Dozier, 3rd, W A, Umar Faruk, M, Francesch, M, Kwakernaak, C, Narcy, A, Nyachoti, C M, Olukosi, O A, Preynat, A, Renouf, B, Saiz Del Barrio, A, Schedle, K, Siegert, W, Steenfeldt, S, van Krimpen, M M, Waititu, S M, Witzig, M

“…The objective of this ring test was to investigate the prececal phosphorus (P) digestibility of soybean meal (SBM) in broiler chickens using the trial protocol…”
Get full text

Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells by Renouf, B, Hollville, É, Pujals, A, Tétaud, C, Garibal, J, Wiels, J

“…p53 inactivation is often observed in Burkitt's lymphoma (BL) cells, because of either mutations in p53 gene or an overexpression of the p53-negative regulator…”
Get full text

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis by Pujals, A, Renouf, B, Robert, A, Chelouah, S, Hollville, É, Wiels, J

“…P53 inactivation is often observed in Burkitt's lymphoma (BL) cells due to mutations in the p53 gene or overexpression of its negative regulator, murine double…”
Get full text

MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes by Mercier, Gilles, Lennon, Anna Maria, Renouf, Benjamin, Dessouroux, Audrey, Ramaugé, Martine, Courtin, Françoise, Pierre, Michel

“…Chronic treatments with antidepressants active on major depressive disorders influence pathways involved in cell survival and plasticity. As astrocytes seem to…”
Get full text